Data / Form D filings / RevivBio Inc.
RevivBio Inc.: Form D filings
RevivBio Inc., a biotechnology company in Cambridge, MA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on January 16, 2024, reports $3 million sold of a $3.2 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 750 MAIN STREET, Cambridge, MA, 02139
- Phone
- (607) 227-2947
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1935963
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | New notice | $3,153,975 | $2,954,976 | $198,999 | 11 | Dec 29, 2023 | sec.gov |
| Oct 4, 2022 | Amendment | $500,000 | $400,000 | $100,000 | 6 | Jun 10, 2022 | sec.gov |
| Jul 5, 2022 | New notice | $250,000 | $137,000 | $113,000 | 4 | Jun 10, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| OXANA AILEEN KUKHANEVA | Director | |
| KARLA AILEEN MILCIC | Director | |
| FATEMEH AILEEN MASTOURI | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jan 15, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RevivBio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.